Skip to main content

Advertisement

SpringerLink
Log in

DOACs levels in patients with hip fracture: is there a relation with renal function and time from last drug intake?

  • CE - LETTER TO THE EDITOR
  • Published:
Internal and Emergency Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

Data are available on request.

References

  1. Tran T, Delluc A, de Wit C, Petrcich W, Le Gal G, Carrier M (2015) The impact of oral anticoagulation on time to surgery in patients hospitalized with hip fracture. Thromb Res 136(5):962–965

    Article  CAS  PubMed  Google Scholar 

  2. Taranu R, Redclift C, Williams P, Diament M, Tate A, Maddox J, Wilson F, Eardley W (2018) Use of anticoagulants remains a significant threat to timely hip fracture surgery. Geriatr Orthop Surg Rehabil 9:2151459318764150. https://doi.org/10.1177/2151459318764150

    Article  PubMed  PubMed Central  Google Scholar 

  3. Viktil K, Lehre I, Ranhoff AH, Espen M (2019) Serum concentrations and elimination rates of direct-acting oral anticoagulants (DOACs) in older hip fracture patients hospitalized for surgery: a pilot study. Drugs Aging 36:65

    Article  CAS  PubMed  Google Scholar 

  4. Steffel J, Verhamme P, Potpara TS et al (2018) The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J 39(16):1330–1393

    Article  CAS  PubMed  Google Scholar 

  5. Schulman S, Angerås U, Bergqvist D, Eriksson B, Lassen MR, Fisher W (2010) Subcommittee on control of anticoagulation of the scientific and standardization committee of the international society on thrombosis and haemostasis. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost 8:202–204. https://doi.org/10.1111/j.1538-7836.2009.03678.x

    Article  CAS  PubMed  Google Scholar 

  6. Douketis JD, Spyropoulos AC, Duncan J, Carrier M, Le Gal G, Tafur AJ, Vanassche T, Verhamme P, Shivakumar S, Gross PL, Lee AYY, Yeo E, Solymoss S, Kassis J, Le Templier G, Kowalski S, Blostein M, Shah V, MacKay E, Wu C, Clark NP, Bates SM, Spencer FA, Arnaoutoglou E, Coppens M, Arnold DM, Caprini JA, Li N, Moffat KA, Syed S, Schulman S (2019) Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant. JAMA Intern Med 179(11):1469–1478. https://doi.org/10.1001/jamainternmed.2019.2431

    Article  PubMed  PubMed Central  Google Scholar 

  7. Squizzato A, Poli D, Barcellona D, Ciampa A, Grandone E, Manotti C, Moia M, Toschi V, Tosetto A, Testa S (2022) Scientific reviewer committee. Management of DOAC in patients undergoing planned surgery or invasive procedure: Italian federation of centers for the diagnosis of thrombotic disorders and the surveillance of the antithrombotic therapies (FCSA) position paper. Thromb Haemost 122(3):329–335. https://doi.org/10.1055/a-1715-5960

    Article  PubMed  Google Scholar 

  8. Godier A, Dincq AS, Martin AC, Radu A, Leblanc I, Antona M, Vasse M, Golmard JL, Mullier F, Gouin-Thibault I (2017) Predictors of pre-procedural concentrations of direct oral anticoagulants: a prospective multicentre study. Eur Heart J 38(31):2431–2439. https://doi.org/10.1093/eurheartj/ehx403

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento Medicina Sperimentale e Clinica, Università di Firenze, Florence, Italy

    Carlo Rostagno, Anna Maria Gori & Rossella Marcucci

  2. Medicina Interna e Post-Chirurgica, AOU Careggi Firenze, Viale Morgagni 85, 50134, Florence, Italy

    Carlo Rostagno & Giulio Maria Mannarino

  3. Traumatologia e Ortopedia, AOU Careggi, Florence, Italy

    Robero Civinini

  4. Malattie Aterotrombotiche, AOU Careggi, Florence, Italy

    Anna Maria Gori & Rossella Marcucci

Authors
  1. Carlo Rostagno
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giulio Maria Mannarino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Robero Civinini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Anna Maria Gori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rossella Marcucci
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

The conception and design of the study, or acquisition of data, or analysis and interpretation of data: CR, GMM, AMG. Drafting the article or revising it critically for important intellectual content, CR, RM, RC. Final approval of the version to be submitted. CR, RM, RC.

Corresponding author

Correspondence to Carlo Rostagno.

Ethics declarations

Human and animal rights

This observational prospective study was approved by Ethical Committee Area Vasta Toscana Centro on February 19th 2019 n° 6590/2109.

Informed consent

All patients gave written informed consent.

Conflict of interest

No conflict of interest is to be declared.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rostagno, C., Mannarino, G.M., Civinini, R. et al. DOACs levels in patients with hip fracture: is there a relation with renal function and time from last drug intake?. Intern Emerg Med (2024). https://doi.org/10.1007/s11739-024-03546-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11739-024-03546-2

Search

Navigation